Miller Steve sold CPRX
August 26, 2025 · Form 4 insider transaction
Miller Steve sold 115,000 shares of Catalyst Pharmaceuticals Inc at $20.28 per share, a transaction worth $2.33M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
115,000
Price
$20.28
Total value
$2.33M
InsiderMiller Steve
Role—
SecurityCommon stock, par value $0.001 per share
Transaction codeS: Open-market sale
Transaction dateAugust 26, 2025
Filing dateAugust 28, 2025
Shares owned after949,663
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold on the open market to fund the exercise price and estimated taxes due from Reporting Person as a result of the exercise of the 225,000 stock options reported on Table II.; Represents a weighted average sale price. Shares were sold in a range from $20.04 to $20.645 per share.